TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive Meta-Analysis.

Cardiol Res Pract · 2026 · PMC13280660 · PMID 42325936

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = 0.14not close (p > 0.1)

However, in the ESRD subgroup, the mortality benefit for TAVR did not reach statistical significance (OR 0.53; 95% CI 0.22–1.24; p = 0.14) (Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.